Welcome to our dedicated page for BXP news (Ticker: BXP), a resource for investors and traders seeking the latest updates and insights on BXP stock.
BXP (Boston Properties) is a leading real estate investment trust (REIT) focused on premier office spaces in major U.S. markets. This page aggregates official announcements, financial updates, and strategic developments for stakeholders tracking the company’s performance.
Access timely updates including quarterly earnings, property acquisitions, sustainability initiatives, and leadership changes. Our curated feed ensures you never miss critical information affecting BXP investment decisions or market positioning.
Key coverage areas include leasing activity in core markets like Boston and San Francisco, development project milestones, and industry trend analysis relevant to commercial real estate. All content is sourced directly from verified company communications.
Bookmark this page for streamlined access to BXP’s evolving story. Check back regularly for objective reporting on one of the REIT sector’s most strategically positioned operators.
BXP (NYSE: BXP) announced the development of two fully pre-leased life sciences projects in Cambridge, Massachusetts, totaling over 800,000 square feet. The first quarter of 2023 saw a revenue increase of 6.5% to $803.2 million compared to $754.3 million in Q1 2022. However, net income dropped significantly from $143.0 million to $77.9 million, primarily due to higher depreciation and interest expenses. Funds from Operations (FFO) also decreased from $286.1 million to $272.0 million. Despite these setbacks, BXP exceeded its FFO guidance but fell short on EPS by $0.03. The company maintains a strong portfolio with about 660,000 square feet of leases executed. Guidance for Q2 2023 EPS is set at $0.59 - $0.61, with FFO projected between $1.79 - $1.81 per share.